Five rare variants in <i>BRIP1/FANCJ</i>, initially identified in ovarian cancer (OC) or breast cancer (BC) cases by the adult hereditary cancer clinics, were investigated for their candidacy as clinically relevant variants. This evidence concerns the gene BRIP1 and hereditary cancer.